Telomere dysfunction of lymphocytes in patients with Alzheimer disease

Jianmin Zhang, Qingli Kong, Zhenxin Zhang, Pingjiang Ge, Denian Ba, Wei He

Research output: Contribution to journalArticle

Abstract

Objective: The objective of this study was to investigate the telomerase activity of phytohemagglutinin-activated lymphocytes from patients with Alzheimer disease. Background: There is impairment of immune function in patients with Alzheimer disease, and the perturbation of immune system is involved the pathogenesis of Alzheimer disease. However, the mechanism of the impairment is unclear so far. Methods: We analyzed telomerase activities of phytohemagglutinin-activated lymphocytes from 187 cases of patients with Alzheimer disease, 53 cases of patients with vascular dementia, and 80 cases of age-matched healthy controls, respectively. Telomerase activity was measured using the telomeric repeat amplification protocol-based telomerase polymerase chain reaction enzyme-linked immunosorbent assay. We also detected the proliferation activity of peripheral blood mononuclear cells from 10 cases of patients with Alzheimer disease or 10 cases of age-matched healthy controls by [3H] thymidine incorporation. Results: Telomerase activity of phytohemagglutinin-activated lymphocytes in Alzheimer disease patients was significantly elevated compared with healthy controls (P <0.01) and vascular dementia patients (P <0.01), respectively. There was significant statistical correlation between the telomerase activities of lymphocytes and the degree of dementia in Alzheimer disease patients. The proliferation activity of peripheral blood mononuclear cells to phytohemagglutinin was significantly decreased in Alzheimer disease patients compared with age-matched healthy controls (P <0.01). Conclusions: Our data suggest that there could be an accelerated telomere dysfunction in lymphocytes of Alzheimer disease patients, which induces the increase of telomerase activity and the decrease of proliferation activity of lymphocytes, and subsequently results in the impairment of immune function in Alzheimer disease patients.

Original languageEnglish (US)
Pages (from-to)170-176
Number of pages7
JournalCognitive and Behavioral Neurology
Volume16
Issue number3
DOIs
StatePublished - Sep 1 2003
Externally publishedYes

Fingerprint

Telomere
Alzheimer Disease
Telomerase
Lymphocytes
Phytohemagglutinins
Vascular Dementia
Blood Cells
Immune System Diseases
Thymidine
Dementia
Enzyme-Linked Immunosorbent Assay
Polymerase Chain Reaction

Keywords

  • Alzheimer disease
  • Lymphocytes
  • Telomerase
  • Telomere

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Behavioral Neuroscience
  • Cognitive Neuroscience

Cite this

Telomere dysfunction of lymphocytes in patients with Alzheimer disease. / Zhang, Jianmin; Kong, Qingli; Zhang, Zhenxin; Ge, Pingjiang; Ba, Denian; He, Wei.

In: Cognitive and Behavioral Neurology, Vol. 16, No. 3, 01.09.2003, p. 170-176.

Research output: Contribution to journalArticle

Zhang, Jianmin ; Kong, Qingli ; Zhang, Zhenxin ; Ge, Pingjiang ; Ba, Denian ; He, Wei. / Telomere dysfunction of lymphocytes in patients with Alzheimer disease. In: Cognitive and Behavioral Neurology. 2003 ; Vol. 16, No. 3. pp. 170-176.
@article{fb3bf6780138497bbfdf9e1ce1598ac9,
title = "Telomere dysfunction of lymphocytes in patients with Alzheimer disease",
abstract = "Objective: The objective of this study was to investigate the telomerase activity of phytohemagglutinin-activated lymphocytes from patients with Alzheimer disease. Background: There is impairment of immune function in patients with Alzheimer disease, and the perturbation of immune system is involved the pathogenesis of Alzheimer disease. However, the mechanism of the impairment is unclear so far. Methods: We analyzed telomerase activities of phytohemagglutinin-activated lymphocytes from 187 cases of patients with Alzheimer disease, 53 cases of patients with vascular dementia, and 80 cases of age-matched healthy controls, respectively. Telomerase activity was measured using the telomeric repeat amplification protocol-based telomerase polymerase chain reaction enzyme-linked immunosorbent assay. We also detected the proliferation activity of peripheral blood mononuclear cells from 10 cases of patients with Alzheimer disease or 10 cases of age-matched healthy controls by [3H] thymidine incorporation. Results: Telomerase activity of phytohemagglutinin-activated lymphocytes in Alzheimer disease patients was significantly elevated compared with healthy controls (P <0.01) and vascular dementia patients (P <0.01), respectively. There was significant statistical correlation between the telomerase activities of lymphocytes and the degree of dementia in Alzheimer disease patients. The proliferation activity of peripheral blood mononuclear cells to phytohemagglutinin was significantly decreased in Alzheimer disease patients compared with age-matched healthy controls (P <0.01). Conclusions: Our data suggest that there could be an accelerated telomere dysfunction in lymphocytes of Alzheimer disease patients, which induces the increase of telomerase activity and the decrease of proliferation activity of lymphocytes, and subsequently results in the impairment of immune function in Alzheimer disease patients.",
keywords = "Alzheimer disease, Lymphocytes, Telomerase, Telomere",
author = "Jianmin Zhang and Qingli Kong and Zhenxin Zhang and Pingjiang Ge and Denian Ba and Wei He",
year = "2003",
month = "9",
day = "1",
doi = "10.1097/00146965-200309000-00004",
language = "English (US)",
volume = "16",
pages = "170--176",
journal = "Cognitive and Behavioral Neurology",
issn = "1543-3633",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Telomere dysfunction of lymphocytes in patients with Alzheimer disease

AU - Zhang, Jianmin

AU - Kong, Qingli

AU - Zhang, Zhenxin

AU - Ge, Pingjiang

AU - Ba, Denian

AU - He, Wei

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Objective: The objective of this study was to investigate the telomerase activity of phytohemagglutinin-activated lymphocytes from patients with Alzheimer disease. Background: There is impairment of immune function in patients with Alzheimer disease, and the perturbation of immune system is involved the pathogenesis of Alzheimer disease. However, the mechanism of the impairment is unclear so far. Methods: We analyzed telomerase activities of phytohemagglutinin-activated lymphocytes from 187 cases of patients with Alzheimer disease, 53 cases of patients with vascular dementia, and 80 cases of age-matched healthy controls, respectively. Telomerase activity was measured using the telomeric repeat amplification protocol-based telomerase polymerase chain reaction enzyme-linked immunosorbent assay. We also detected the proliferation activity of peripheral blood mononuclear cells from 10 cases of patients with Alzheimer disease or 10 cases of age-matched healthy controls by [3H] thymidine incorporation. Results: Telomerase activity of phytohemagglutinin-activated lymphocytes in Alzheimer disease patients was significantly elevated compared with healthy controls (P <0.01) and vascular dementia patients (P <0.01), respectively. There was significant statistical correlation between the telomerase activities of lymphocytes and the degree of dementia in Alzheimer disease patients. The proliferation activity of peripheral blood mononuclear cells to phytohemagglutinin was significantly decreased in Alzheimer disease patients compared with age-matched healthy controls (P <0.01). Conclusions: Our data suggest that there could be an accelerated telomere dysfunction in lymphocytes of Alzheimer disease patients, which induces the increase of telomerase activity and the decrease of proliferation activity of lymphocytes, and subsequently results in the impairment of immune function in Alzheimer disease patients.

AB - Objective: The objective of this study was to investigate the telomerase activity of phytohemagglutinin-activated lymphocytes from patients with Alzheimer disease. Background: There is impairment of immune function in patients with Alzheimer disease, and the perturbation of immune system is involved the pathogenesis of Alzheimer disease. However, the mechanism of the impairment is unclear so far. Methods: We analyzed telomerase activities of phytohemagglutinin-activated lymphocytes from 187 cases of patients with Alzheimer disease, 53 cases of patients with vascular dementia, and 80 cases of age-matched healthy controls, respectively. Telomerase activity was measured using the telomeric repeat amplification protocol-based telomerase polymerase chain reaction enzyme-linked immunosorbent assay. We also detected the proliferation activity of peripheral blood mononuclear cells from 10 cases of patients with Alzheimer disease or 10 cases of age-matched healthy controls by [3H] thymidine incorporation. Results: Telomerase activity of phytohemagglutinin-activated lymphocytes in Alzheimer disease patients was significantly elevated compared with healthy controls (P <0.01) and vascular dementia patients (P <0.01), respectively. There was significant statistical correlation between the telomerase activities of lymphocytes and the degree of dementia in Alzheimer disease patients. The proliferation activity of peripheral blood mononuclear cells to phytohemagglutinin was significantly decreased in Alzheimer disease patients compared with age-matched healthy controls (P <0.01). Conclusions: Our data suggest that there could be an accelerated telomere dysfunction in lymphocytes of Alzheimer disease patients, which induces the increase of telomerase activity and the decrease of proliferation activity of lymphocytes, and subsequently results in the impairment of immune function in Alzheimer disease patients.

KW - Alzheimer disease

KW - Lymphocytes

KW - Telomerase

KW - Telomere

UR - http://www.scopus.com/inward/record.url?scp=0141954270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141954270&partnerID=8YFLogxK

U2 - 10.1097/00146965-200309000-00004

DO - 10.1097/00146965-200309000-00004

M3 - Article

VL - 16

SP - 170

EP - 176

JO - Cognitive and Behavioral Neurology

JF - Cognitive and Behavioral Neurology

SN - 1543-3633

IS - 3

ER -